Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HeartLung.AI
Houston, Texas, United Statesheartlung.ai ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
HeartLung.AI has achieved FDA clearance for its opportunistic bone mineral density measurement tool (AutoBMD™) and its cardiac chamber volumetry tool (AutoChamber™), both of which leverage existing CT scans to detect osteoporosis and hidden heart risks. The company’s technologies have received "Breakthrough Device" designation from the FDA. Clinical studies presented at major cardiology conferences demonstrate the potential of these tools to identify patients at high risk for fatal diseases earlier than standard care allows. Additional modules targeting coronary artery calcium scoring and comprehensive cardiovascular risk assessment are in advanced stages of development or regulatory review
- Therapeutic areas
- PulmonologyGastroenterologyEndocrinologyOncologyCardiovascular
- Modalities
- Device (AI-enabled software as a medical device)
- Industry
- Medical Imaging
02
Partnerships
SimonMed Imaging
Beyond the preview
Go deeper on HeartLung.AI.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HeartLung.AI.